TEVA Pharmaceuticals Slovakia s.r.o.
ActiveKey figures
Key figures
2025Summary: TEVA Pharmaceuticals Slovakia s.r.o.
What kind of company is it?
TEVA Pharmaceuticals Slovakia s.r.o. (IČO 35923253) is a limited liability company (s.r.o.). The company was incorporated in 2005 and has existed for 21 years. Registered office according to the register: Bratislava. Main activity according to the Statistical Office: veľkoobchod s farmaceutickým a zdravotníckym tovarom (SK NACE 4646). Size category by number of employees: 50–99 employees.
Who runs the company and who owns it?
The statutory body has 2 members. According to the register, the company has one shareholder. The registered capital is 298 746 €.
How is the company doing financially?
Revenue for 2025 was 63 282 461 €, up 7,1 % on the previous year (59 103 050 €). From 2020 to 2025, revenue grew by an average of 5,4 % per year. This is the highest revenue in the reported years (2020–2025). Net profit for 2025 was 957 451 € (1,5 % of revenue). The company was profitable in all 6 reported years. Personnel costs for 2025 were 4 278 192 €. At the end of 2025 the company had total assets of 53 519 477 € and equity of 13 070 035 € (equity ratio 24,4 %).
Where does the data come from and how current is it?
Company and people data come from the Register of Legal Entities (Statistical Office SR, CC BY 4.0) and financial statements from the Register of Financial Statements (Ministry of Finance SR); icoprofil.sk updates them daily. Data as of 11. 11. 2026. Changes, averages and ratios are calculated by icoprofil.sk from open data and are not an official assessment.
Summary of annual reports2020–2025
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Revenue (net turnover) | 51 526 190 | 52 312 760 | 56 174 558 | 59 103 050 | 63 282 461 |
| Profit for the reporting year | 711 006 | 564 587 | 1 201 044 | 624 137 | 957 451 |
| Retained earnings of previous periods | 8 683 189 | 9 394 195 | 9 958 782 | 11 159 826 | 11 783 963 |
| Total assets | 36 144 444 | 42 158 229 | 50 659 303 | 52 634 357 | 53 519 477 |
| Total liabilities | 26 421 628 | 31 870 826 | 39 170 856 | 40 521 773 | 40 449 442 |
| Total equity | 9 722 816 | 10 287 403 | 11 488 447 | 12 112 584 | 13 070 035 |
| Calculated dividends | 0 | 0 | 0 | 0 | 0 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
Documents in the Register of Financial Statements20
- 2025 Oznámenie o dátume schválenia účtovnej závierky · 1 pp.
- 2025 Správa audítora
- 2025 Úč POD · 12 pp.
- 2025 Úč POD
- 2024 Oznámenie o dátume schválenia účtovnej závierky · 1 pp.
- 2024 Správa audítora
- 2024 Úč POD · 12 pp.
- 2024 Úč POD
- 2023 Oznámenie o dátume schválenia účtovnej závierky · 1 pp.
- 2023 Správa audítora
- 2023 Úč POD · 12 pp.
- 2023 Úč POD
- 2022 Oznámenie o dátume schválenia účtovnej závierky · 1 pp.
- 2022 Správa audítora
- 2022 Úč POD · 12 pp.
- 2022 Úč POD
- 2021 Oznámenie o dátume schválenia účtovnej závierky · 1 pp.
- 2021 Správa audítora
- 2021 Úč POD · 12 pp.
- 2021 Úč POD
Documents open directly on registeruz.sk (Ministry of Finance of the Slovak Republic).
Similar companies
- PHARMAGEN s.r.o. · Bratislava - mestská časť Ružinov
- A.IMPORT.SK, spol. s r.o. · Bratislava
- GLENMARK PHARMACEUTICALS SK, s. r. o. · Bratislava
- MagnaPharm SK s. r. o. · Bratislava - mestská časť Petržalka
- Slovakiapharm, a.s. · Nové Zámky
- ZAR Services, s. r. o. · Svätý Jur
- CURADEN Slovakia s.r.o. · Bratislava - mestská časť Ružinov
- Neuraxpharm Slovakia, a. s. · Bratislava
- MedaPreX SK, s.r.o. · Bratislava
- PHARMOS, a.s. v konkurze · Nitra